<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Ironwood Gets $75M Deal From Astellas to Market Bowel Drug in Asia</title>
	<atom:link href="http://www.xconomy.com/boston/2009/11/10/ironwood-gets-75m-deal-from-astellas-to-market-bowel-drug-in-asia/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/11/10/ironwood-gets-75m-deal-from-astellas-to-market-bowel-drug-in-asia/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: &#187; Ironwood Receives $75M from Astellas for IBS Drug &#124; OneMedPlace &#187; Archive</title>
		<link>http://www.xconomy.com/boston/2009/11/10/ironwood-gets-75m-deal-from-astellas-to-market-bowel-drug-in-asia/comment-page-1/#comment-91761</link>
		<dc:creator>&#187; Ironwood Receives $75M from Astellas for IBS Drug &#124; OneMedPlace &#187; Archive</dc:creator>
		<pubDate>Thu, 12 Nov 2009 04:32:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49841#comment-91761</guid>
		<description>[...] such company is Ironwood Pharmaceuticals. The Cambridge, Mass.-based company has signed a $75 million deal with Astellas Pharmaceuticals to market Ironwood&#8217;s IBS drug in Asia.  In exchange, Astellas [...]</description>
		<content:encoded><![CDATA[<p>[...] such company is Ironwood Pharmaceuticals. The Cambridge, Mass.-based company has signed a $75 million deal with Astellas Pharmaceuticals to market Ironwood’s IBS drug in Asia.  In exchange, Astellas [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

